Effects of oxidized low density lipoprotein on transformation of valvular myofibroblasts to osteoblast-like phenotype

Abstract

In order to investigate the roles of Wnt signal pathway in transformation of cardiac valvular myofibroblasts to the osteoblast-like phenotype, the primary cultured porcine aortic valve myofibroblasts were incubated with oxidized low density lipoprotein (ox-LDL, 50 mg/L), and divided into four groups according to the ox-LDL treatment time: control group, ox-LDL 24-h group, ox-LDL 48-h group, and ox-LDL 72-h group. Wnt signal pathway blocker Dickkopf-1 (DDK-1, 100 μg/L) was added in ox-LDL 72-h group. The expression of a-smooth muscle actin (α-SMA), bone morphogenetic protein 2 (BMP2), alkaline phosphatase (ALP), and osteogenic transcription factor Cbfa-1 was detected by Western blotting, and that of β-catenin, a key mediator of Wnt signal pathway by immunocytochemical staining method. The Wnt/β-catenin was observed and the transformation of myofibroblasts to the osteoblast-like phenotype was examined. The expression of α-SMA, BMP2, ALP and Cbfa-1 proteins in the control group was weaker than in the ox-LDL-treated groups. In ox-LDL-treated groups, the protein expression of a-SMA, BMP2, ALP, and Cbfa-1 was significantly increased in a time-dependent manner as compared with the control group, and there was significant difference among the three ox-LDL-treated groups (P<0.05 for all); β-catenin protein was also up-regulated in the ox-LDL-treated groups in a time-dependent manner as compared with the control group (P<0.05), and its transfer from cytoplasm to nucleus and accumulation in the nucleus were increased in the same fashion (P<0.05). After addition of DKK-1, the expression of α-SMA, bone-related proteins and β-catenin protein was significantly reduced as compared with ox-LDL 72-h group (P<0.05). The Wnt/ β-catenin signaling pathway may play an important role in transformation of valvular myofibroblasts to the osteoblast-like phenotype.

Keywords

oxidized low density lipoprotein / cardiac valve calcification / myofibroblasts / Wnt/β-catenin / osteoblasts

References

[1] MathieuP, BoulangerMC. Basic mechanisms of calcifyic aortic valve disease. Can J Cardiol, 2014, 30(9): 982-993 PMID: 25085215

[2] TowlerDA. Molecular and cellular aspects of calcific aortic valve disease. Circ Res, 2013, 113(2): 198-208 PMCID: 4057916 PMID: 23833294

[3] RajamannanNM, EvansFJ, AikawaE, et al. . Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update. Circulation, 2011, 124(16): 1783-1791 PMCID: 3306614 PMID: 22007101

[4] NightingaleAK, HorowitzJD. Aortic sclerosis: not an innocent murmur but a marker of increased cardiovascular risk. Heart, 2005, 91(11): 1389-1393 PMCID: 1769170 PMID: 15797932

[5] ZhongZ, EthenNJ, WiliamsBO. Wnt signaling in bone development and homeostasis. Wiley Interdiscip Rev Dev Biol, 2014, 3(6): 489-500 PMID: 25270716

[6] AbedinM, TintutY, DemerLL. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol, 2004, 24(7): 1161-1170 PMID: 15155384

[7] CoteC, PibarotP, DespresJP, et al. . Association between circulating oxidised low-density lipoprotein and fibrocalcific remodeling of theaortic valve in aortic stenosis. Heart, 2008, 94(9): 1175-1180 PMID: 17932090

[8] DichtlW, AlberHF, FeuchtnerGM, et al. . Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg). Am J Cardiol, 2008, 102(6): 743-748 PMID: 18774000

[9] LiuAC, JoagVR, GotliebAI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol, 2007, 171(5): 1407-1418 PMCID: 2043503 PMID: 17823281

[10] LiuAC, GotliebAL. Characterization of cell motility in single heart valve interstitial cells in vitro. Histol Histopathol, 2007, 22(8): 873-882 PMID: 17503344

[11] TaylorPM, BattenP, BrandNJ, et al. . The cardiac valve interstitial cell. Int J Biochem Cell Biol, 2003, 35(2): 113-118 PMID: 12479860

[12] RajamannanNM, SubramaniamM, CairaF, et al. . Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation, 2005, 112(9): 229-234

[13] MerrymanWD, LukoffHD, LongRA, et al. . Synergistic effects of cyclic tension and transforming growth factor-beta1 on the aortic valve myofibroblast. Cardiovasc Pathol, 2007, 16(5): 268-276 PMCID: 2094120 PMID: 17868877

[14] KadenJJ, KilicR, SarikocA, et al. . Tumor necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: a potential regulatory mechanism of valvular calcification. Int J Mol Med, 2005, 16(5): 869-872 PMID: 16211257

[15] KadenJJ, DempfleCE, KilicR, et al. . Influence of receptor activator of nuclear factor kappa B on human aortic valve myofibroblasts. Exp Mol Pathol, 2005, 78(1): 36-40 PMID: 15596058

[16] CleversH. Wnt/β-Catenin signaling in development and disease. Cell, 2006, 127(3): 469-480 PMID: 17081971

[17] CleversH, van de WeteringM. TCF/LEF factor earn their wings. Trends Genet, 1997, 13(12): 485-489 PMID: 9433138

[18] HurlstoneAF, HaramisAP, WienholdsE. The Wnt/β-catenin pathway regulates cardiac valve formation. Nature, 2003, 425(9): 633-637 PMID: 14534590

[19] GoodwinAM, D’AmorePA. Wnt signaling in the vasculature. Angiogenesis, 2002, 5(1): 1-9 PMID: 12549854

[20] FavermanL, MikhaylovaL, MalmquistJ, et al. . Extracellular transglutaminase 2 activates b-catenin signaling in calcifying vascular smooth muscle cells. FEBS Letters, 2008, 582(10): 1552-1557 PMID: 18405667